The Effect of Perioperative Lidocaine Intravenous Infusion on Postoperative Recovery After Spine Surgery.
Overview
- Phase
- Phase 4
- Intervention
- Lidocaine
- Conditions
- Spinal Diseases
- Sponsor
- Sheba Medical Center
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Postoperative pain
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the effectiveness of perioperative Lidocaine intravenous infusion in reducing postoperative pain for spine surgery patients.
Detailed Description
Study design: this study used a prospective, randomized, double-blinded, and placebo-controlled clinical trial. Sixty patients scheduled for a spine surgery will be randomly assigned to two groups. Lidocaine group will receive an intravenous bolus injection of lidocaine 1.5 mg/kg before intubation, followed by 2 mg/kg/h continuous infusion during the operation. Placebo group will receive the same dosage of saline at the same time. Analgesic requirement will be monitored using patient-controlled Analgesia (PCA protocol: demand dose is 2 mg of morphine, lockout 5 min, maximum dose 15 mg per hour). Forty-eight hours after surgery, we will check the morphine consumption in two groups. Quality of recovery after surgery will be assessed using Q0R15 questionnaire.
Investigators
Eligibility Criteria
Inclusion Criteria
- •spine surgery with general anesthesia
Exclusion Criteria
- •lidocaine allergy
- •hepatic disease
- •dementia or cognitive decline
Arms & Interventions
Lidocaine
Patients will receive Lidocaine drip during spine surgery
Intervention: Lidocaine
Placebo
Patients will receive placebo during spine surgery
Intervention: Lidocaine
Outcomes
Primary Outcomes
Postoperative pain
Time Frame: 24 hours postop
Quality of recovery after surgery will be assessed using Q0R15 questionnaire and analgesic requirement will be monitored using PCA